The Pharmacogenomics Journal http://www.nature.com/tpj/current_issue/ Nature Publishing Group en Copyright © Nature Publishing Group The Pharmacogenomics Journal 1470-269X Copyright © Nature Publishing Group permissions@nature.com The Pharmacogenomics Journal http://www.nature.com/aj/images/logos_b_o_w/tpj.gif http://www.nature.com/tpj/ Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility http://dx.doi.org/10.1038/tpj.2008.3 Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility

The Pharmacogenomics Journal 8, 365 (December 2008). doi:10.1038/tpj.2008.3

Authors: A R Hughes, W R Spreen, M Mosteller, L L Warren, E H Lai, C H Brothers, C Cox, A J Nelsen, S Hughes, D E Thorborn, B Stancil, S V Hetherington, D K Burns & A D Roses

]]> Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility A R Hughes W R Spreen M Mosteller L L Warren E H Lai C H Brothers C Cox A J Nelsen S Hughes D E Thorborn B Stancil S V Hetherington D K Burns A D Roses doi:10.1038/tpj.2008.3 The Pharmacogenomics Journal 8, 365 (December 2008) March 11, 2008 The Pharmacogenomics Journal March 11, 2008 8 6 365 374 Repeated clomipramine treatment reversed the inhibition of cell proliferation in adult hippocampus induced by chronic unpredictable stress http://dx.doi.org/10.1038/sj.tpj.6500485 Repeated clomipramine treatment reversed the inhibition of cell proliferation in adult hippocampus induced by chronic unpredictable stress

The Pharmacogenomics Journal 8, 375 (December 2008). doi:10.1038/sj.tpj.6500485

Authors: Q Liu, J Yu, Q-L Mao-Ying, W-L Mi, B Li, Y-Q Wang, J Wang & G-C Wu

]]> Repeated clomipramine treatment reversed the inhibition of cell proliferation in adult hippocampus induced by chronic unpredictable stress Q Liu J Yu Q-L Mao-Ying W-L Mi B Li Y-Q Wang J Wang G-C Wu doi:10.1038/sj.tpj.6500485 The Pharmacogenomics Journal 8, 375 (December 2008) January 15, 2008 The Pharmacogenomics Journal January 15, 2008 8 6 375 383 Glycogen synthase kinase-3β gene is associated with antidepressant treatment response in Chinese major depressive disorder http://dx.doi.org/10.1038/sj.tpj.6500486 Glycogen synthase kinase-3β gene is associated with antidepressant treatment response in Chinese major depressive disorder

The Pharmacogenomics Journal 8, 384 (December 2008). doi:10.1038/sj.tpj.6500486

Authors: S-J Tsai, Y-J Liou, C-J Hong, Y W-Y Yu & T-J Chen

]]> Glycogen synthase kinase-3β gene is associated with antidepressant treatment response in Chinese major depressive disorder S-J Tsai Y-J Liou C-J Hong Y W-Y Yu T-J Chen doi:10.1038/sj.tpj.6500486 The Pharmacogenomics Journal 8, 384 (December 2008) January 15, 2008 The Pharmacogenomics Journal January 15, 2008 8 6 384 390 Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment http://dx.doi.org/10.1038/sj.tpj.6500492 Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment

The Pharmacogenomics Journal 8, 391 (December 2008). doi:10.1038/sj.tpj.6500492

Authors: D F Heitjan, D A Asch, Riju Ray, Margaret Rukstalis, Freda Patterson & C Lerman

]]> Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment D F Heitjan D A Asch Riju Ray Margaret Rukstalis Freda Patterson C Lerman doi:10.1038/sj.tpj.6500492 The Pharmacogenomics Journal 8, 391 (December 2008) March 18, 2008 The Pharmacogenomics Journal March 18, 2008 8 6 391 399 Interaction between polymorphisms in the renin–angiotensin–system and angiotensin-converting enzyme inhibitor or β-blocker use and the risk of myocardial infarction and stroke http://dx.doi.org/10.1038/sj.tpj.6500493 Interaction between polymorphisms in the renin–angiotensin–system and angiotensin-converting enzyme inhibitor or β-blocker use and the risk of myocardial infarction and stroke

The Pharmacogenomics Journal 8, 400 (December 2008). doi:10.1038/sj.tpj.6500493

Authors: H Schelleman, O H Klungel, J C M Witteman, M M B Breteler, A Hofman, C M van Duijn, A de Boer & B H Ch Stricker

]]> Interaction between polymorphisms in the renin–angiotensin–system and angiotensin-converting enzyme inhibitor or β-blocker use and the risk of myocardial infarction and stroke H Schelleman O H Klungel J C M Witteman M M B Breteler A Hofman C M van Duijn A de Boer B H Ch Stricker doi:10.1038/sj.tpj.6500493 The Pharmacogenomics Journal 8, 400 (December 2008) March 18, 2008 The Pharmacogenomics Journal March 18, 2008 8 6 400 407 β-Adrenergic receptor gene polymorphisms and hemodynamic response to dobutamine during dobutamine stress echocardiography http://dx.doi.org/10.1038/sj.tpj.6500490 β-Adrenergic receptor gene polymorphisms and hemodynamic response to dobutamine during dobutamine stress echocardiography

The Pharmacogenomics Journal 8, 408 (December 2008). doi:10.1038/sj.tpj.6500490

Authors: C L Aquilante, H N Yarandi, L H Cavallari, T E Andrisin, S G Terra, J F Lewis, K K Hamilton & J A Johnson

]]> β-Adrenergic receptor gene polymorphisms and hemodynamic response to dobutamine during dobutamine stress echocardiography C L Aquilante H N Yarandi L H Cavallari T E Andrisin S G Terra J F Lewis K K Hamilton J A Johnson doi:10.1038/sj.tpj.6500490 The Pharmacogenomics Journal 8, 408 (December 2008) February 5, 2008 The Pharmacogenomics Journal February 5, 2008 8 6 408 415 CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine http://dx.doi.org/10.1038/sj.tpj.6500488 CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine

The Pharmacogenomics Journal 8, 416 (December 2008). doi:10.1038/sj.tpj.6500488

Authors: R Kreutz, J Bolbrinker, F van der Sman-de Beer, E W Boeschoten, F W Dekker, S Kain, P Martus, A Sietmann, F Friedrichs, M Stoll, G Offermann & J Beige

]]> CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine R Kreutz J Bolbrinker F van der Sman-de Beer E W Boeschoten F W Dekker S Kain P Martus A Sietmann F Friedrichs M Stoll G Offermann J Beige doi:10.1038/sj.tpj.6500488 The Pharmacogenomics Journal 8, 416 (December 2008) January 8, 2008 The Pharmacogenomics Journal January 8, 2008 8 6 416 422